Table 2 Comparisons of latecomer patients according to their revascularization therapies
Non-PCI (n = 38) | PCI (n = 126) | P value | |
|---|---|---|---|
In hospital medications | |||
IABP + ECMO | 1 (2.6) | 10 (7.9) | 0.463 |
CPR | 0 (0.0) | 2 (1.6) | 0.863 |
Pacemaker | 0 (0.0) | 3 (2.4) | 0.331 |
Vasoactive agents | 16 (42.1) | 41 (32.5) | 0.332 |
Diuretics | 24 (63.2) | 72 (57.1) | 0.029 |
CIN | 0(0.0) | 0(0.0) | NA |
Complications at 30 days | |||
All-cause death | 11 (28.9) | 14 (11.1) | 0.018 |
Heart failure | 3 (7.9) | 6 (4.8) | 0.457 |
Unstable angina pectoris | 3 (7.9) | 0 (0.0) | 0.012 |
Malignant arrhythmia | 0 (0.0) | 0 (0.0) | NA |
Cardiac rupture | 0 (0.0) | 0 (0.0) | NA |
Re-infarction | 0 (0.0) | 0 (0.0) | NA |
LVEDd, mm | 49.0 ± 8.3 | 53.6 ± 8.0 | 0.248 |
LVEF, % | 53.3 ± 15.3 | 51.5 ± 11.8 | 0.219 |
Complications at 1 year | |||
All-cause death | 17 (44.7) | 51 (40.4) | 0.708 |
Heart failure | 6 (15.8) | 9 (7.1) | 0.116 |
Unstable angina pectoris | 3 (7.9) | 0 (0.0) | 0.012 |
Malignant arrhythmia | 1 (2.6) | 0 (0.0) | 0.232 |
Cardiac rupture | 0 (0.0) | 0(0.0) | NA |
Re-infarction | 0 (0.0) | 0(0.0) | NA |
LVEDd, mm | 47.3 ± 7.5 | 51.8 ± 6. 1 | 0.281 |
LVEF, % | 53.8 ± 12.4 | 56.4 ± 10.0 | 0.073 |